News | April 19, 2022
Akron Bio completes plasmid DNA manufacturing facility
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
Subscribe To Our Newsletter & Stay Updated
